ACG: this morning announcement is quite signficant which open up its products to world largest market, USA.
Only 151.7m shares. $4.1m cash. FY13 is $2.7m NPAT.
However, first half of FY14 was a set back with revenue down 50% and loss of $1m. More revenue expects in 2nd half.
Blood pressure devices with $100m global market and ACG is well position to capitalise on it.
Was as high as 22.5c.
